| Income Statement |
| Total Revenue | 1.84B |
|
| Revenues (USD) | 1.84B |
| Cost of Revenue | 203.63M |
| Gross Profit | 1.64B |
| Operating Expenses | 198.88M |
| Research and Development Expense | 94.10M |
| Selling, General and Administrative Expense | 104.78M |
| Operating Income | 1.44B |
| Interest Expense | 51.16M |
| Income Tax Expense | 225.80M |
| Net Income | 1.21B |
| Net Income Common Stock | 1.21B |
| Net Income Common Stock (USD) | 1.21B |
| Consolidated Income | 1.21B |
| Earnings per Basic Share | 3.57 |
| Earnings per Basic Share (USD) | 3.57 |
| Earnings per Diluted Share | 3.56 |
| Earning Before Interest & Taxes (EBIT) | 1.48B |
| Earning Before Interest & Taxes (USD) | 1.48B |
| Weighted Average Shares | 337.40M |
| Weighted Average Shares Diluted | 338.73M |
| Balance Sheet |
| Cash and Equivalents | 2.76B |
| Cash and Equivalents (USD) | 2.76B |
| Investments | 288.67M |
| Investments Non-Current | 288.67M |
| Trade and Non-Trade Receivables | 1.96B |
| Current Assets | 4.85B |
| Property, Plant & Equipment Net | 114.82M |
| Total Assets | 7.71B |
| Total Debt | 3.51B |
| Current Liabilities | 1.49B |
| Debt Non-Current | 3.51B |
| Total Liabilities | 5.34B |
| Accumulated Retained Earnings (Deficit) | 1.93B |
| Accumulated Other Comprehensive Income | -67.77M |
| Shareholders Equity | 2.36B |
| Shareholders Equity (USD) | 2.36B |
| Assets Non-Current | 2.86B |
| Total Debt (USD) | 3.51B |
| Goodwill and Intangible Assets | 1.89B |
| Liabilities Non-Current | 3.85B |
| Trade and Non-Trade Payables | 697.52M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 33.67M |
| Net Cash Flow from Financing | -1.01B |
| Net Cash Flow / Change in Cash & Cash Equivalents | 271.58M |
| Issuance (Purchase) of Equity Shares | -981.72M |
| Net Cash Flow from Investing | -5.25M |
| Net Cash Flow from Operations | 1.29B |
| Effect of Exchange Rate Changes on Cash | -2.34M |
| Share Based Compensation | 83.37M |